Biotechnology and pharmaceutical companies seeking to train employees, or even to create their own "online university" can now partner with The Pharmaceutical Institute (PI, Raleigh, NC, www.pharmainstitute.com).
Biotechnology and pharmaceutical companies seeking to train employees, or even to create their own “online university” can now partner with The Pharmaceutical Institute (PI) of Raleigh, NC (www.pharmainstitute.com). PI, a subsidiary of the consulting firm Campbell Alliance, launched its “Corporate Academy Program” in June. The program allows industry clients to implement a training infrastructure without having to set up their own learning management system (LMS).
“We realized there are a lot of small companies or work groups within large companies that have an interest in training, but they don’t have the resources to commit to evaluating, purchasing, and implementing an LMS, maintaining that system, developing new content, or going out and surveying the universe of available content and keep it running for their employees,” said Dan Blue, executive director of PI. “We can set it all up for them with a turn-key solution that allows users to get up and running fairly quickly.”
Clients have the option of using their own proprietary educational material, using PI’s resources, using material licensed by PI from outside vendors, or any combination of all three to customize an educational program for employees.
Services available include:
Although the system originally was designed for small- to mid-size companies, Craig Dunkley, vice president of marketing for Campbell Alliance, says the program’s flexibility also makes it suitable for work groups within large corporations. “If individual work groups within [a large pharmaceutical] company come to us and want to work on developing a corporate academy, we’re certainly happy to do that,” he said.
Cost to the client for participating in the Corporate Academy Program is determined by the number of participants and the amount of educational content, per the terms of each individual agreement.
–Pam Holland-Moritz
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.